Schott Pharma AG & CO KGaA annual net income
2020
2021
2022
2023
2024
2025
Schott Pharma AG & CO KGaA Net Income Growth & History (1SXP)
Schott Pharma AG & CO KGaA's net income was €147.0M for fiscal 2025.
View full Schott Pharma AG & CO KGaA company overviewSchott Pharma AG & CO KGaA annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €147.0M | −€3.4M | −2.24% |
| 2024 | 2024-09-30 | €150.3M | −€1.6M | −1.05% |
| 2023 | 2023-09-30 | €151.9M | €26.1M | +20.73% |
| 2022 | 2022-09-30 | €125.8M | €24.7M | +24.39% |
| 2021 | 2021-09-30 | €101.2M | €23.5M | +30.32% |
| 2020 | 2020-09-30 | €77.6M | — | — |
Schott Pharma AG & CO KGaA quarterly net income
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | €38.8M | −€6.6M | −14.53% |
| Q2 2026 | 2026-03-31 | €31.0M | −€7.1M | −18.68% |
| Q1 2026 | 2025-12-31 | €33.2M | — | — |
| Q4 2025 | 2025-09-30 | €33.6M | — | — |
| Q3 2025 | 2025-06-30 | €45.4M | — | — |
| Q2 2025 | 2025-03-31 | €38.1M | — | — |
Schott Pharma AG & CO KGaA net income trends
Over the last five fiscal years, Schott Pharma AG & CO KGaA's net income increased from €77.6M to €147.0M, a change of €69.4M. The latest reported quarter, Q3 2026, shows €38.8M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company official filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Schott Pharma AG & CO KGaA source filings ↗